Cardiovascular safety profile of dapoxetine during the premarketing evaluation.

Kowey PR, Mudumbi RV, Aquilina JW, DiBattiste PM. Cardiovascular safety profile of dapoxetine during the premarketing evaluation. Drugs R D. 2011; 11(1):1-11.

View in: PubMed

subject areas

Animals
Benzylamines
Cardiovascular System
Clinical Trials as Topic
Dose-Response Relationship, Drug
Drug Evaluation, Preclinical
Humans
Naphthalenes
Syncope, Vasovagal

authors with profiles

Peter Kowey

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement